Correlagen Diagnostics

New Products

Premium

Illumina cBot, Correlagen CardioGeneScan

The assay, Correlagen Diagnostics' first to run on a next-generation sequencer, will cover approximately 300 genes associated with hereditary cardiovascular disease. Going forward, the genetic testing company plans to use the Helicos system for other assays in the areas of endocrinology, neuropsychiatry, and immunology.

Correlagen, which has a CLIA-certified laboratory and is based in Waltham, Mass., plans to use the Helicos platform for new genetic tests that require resequencing "broad panels" of genes in the areas of cardiology, endocrinology, neuropsychiatry, and immunology.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.